Similarly, Giannelli and colleagues previously showed that higher baseline plasma ERBB3 levels were significantly associated with poor survival (HR = 2.21, p < 0.001) in patients with advanced HCC [19]. Here, ERBB3 is linked to hepatocellular carcinoma.